- Home
- ONFO vs CNSP Comparison
ONFO vs CNSP Comparison
Compare ONFO & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONFO
- CNSP
- Stock Information
- Founded
- ONFO 2018
- CNSP 2017
- Country
- ONFO United States
- CNSP United States
- Employees
- ONFO N/A
- CNSP N/A
- Industry
- ONFO Computer Software: Programming Data Processing
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- ONFO Technology
- CNSP Health Care
- Exchange
- ONFO Nasdaq
- CNSP Nasdaq
- Market Cap
- ONFO 6.2M
- CNSP 5.6M
- IPO Year
- ONFO 2022
- CNSP 2019
- Fundamental
- Price
- ONFO $0.93
- CNSP $1.25
- Analyst Decision
- ONFO
- CNSP Hold
- Analyst Count
- ONFO 0
- CNSP 1
- Target Price
- ONFO N/A
- CNSP N/A
- AVG Volume (30 Days)
- ONFO 31.1K
- CNSP 332.7K
- Earning Date
- ONFO 05-20-2025
- CNSP 05-14-2025
- Dividend Yield
- ONFO N/A
- CNSP N/A
- EPS Growth
- ONFO N/A
- CNSP N/A
- EPS
- ONFO N/A
- CNSP N/A
- Revenue
- ONFO $6,590,171.00
- CNSP N/A
- Revenue This Year
- ONFO $133.59
- CNSP N/A
- Revenue Next Year
- ONFO N/A
- CNSP N/A
- P/E Ratio
- ONFO N/A
- CNSP N/A
- Revenue Growth
- ONFO 29.25
- CNSP N/A
- 52 Week Low
- ONFO $0.39
- CNSP $1.21
- 52 Week High
- ONFO $1.88
- CNSP $800.00
- Technical
- Relative Strength Index (RSI)
- ONFO 40.53
- CNSP 30.28
- Support Level
- ONFO $0.61
- CNSP $1.28
- Resistance Level
- ONFO $1.38
- CNSP $1.46
- Average True Range (ATR)
- ONFO 0.11
- CNSP 0.38
- MACD
- ONFO -0.03
- CNSP -0.12
- Stochastic Oscillator
- ONFO 41.34
- CNSP 1.18
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.